Zhongyou Health
Pharmaceutical solutions for cardiovascular and nervous systems
About Zhongyou Health
Gansu Zhongyou Pharmaceutical Group Co. Ltd. operates in China's pharmaceutical sector, which is the second-largest in the world. The company focuses on producing pharmaceutical preparations targeting several key areas of medicine. These include treatments for the cardiovascular system, such as hypotensive agents, as well as drugs for the central and autonomic nervous systems, including analgesics and anesthetics.
The broader Chinese healthcare market is experiencing significant growth, driven by an aging population, a rising middle class, and strong government policy support aimed at fostering self-sufficiency. The industry is shifting from manufacturing-led growth to one driven by innovation and services. This environment has been shaped by regulatory reforms designed to increase research and development capabilities and to reduce the time it takes to launch new drugs. As a result, China has become a major contributor to global pharmaceutical innovation.
Source: Dealroom company dataNews
Open roles
Zhongyou Health in its local ecosystem
The Zhongyou Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Zhongyou Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zhongyou Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.